Schedule Ten—Search warrant
Drugs, Poisons and Controlled Substances Act 1981
To a police officer
WHEREAS I, the undersigned, a *Magistrate in the State of Victoria, am satisfied by the *evidence on oath or affirmation or *by affidavit of:
a police officer of or above the rank of Sergeant or for the time being in charge of a police station, that there is reasonable ground for believing
that there *is on or in a certain
*are
*will be within the next
72 hours
*land or
*premises situate at or
*vehicle identified by
located in a public place *certain things
*certain
documents
to wit:
*(1) upon or in respect of which an offence under the Drugs Poisons and Controlled Substances Act 1981 or the Regulations under that Act, has been or is reasonably suspected to have been committed or is being or is likely to be committed within the next 72 hours;
*(2) which there is reasonable ground to believe will afford evidence of the commission of an offence under the Drugs Poisons and Controlled Substances Act 1981 or the Regulations under that Act;
*(3) which is a document directly or indirectly relating to or concerning a transaction or dealing which is or would be, if carried out, an offence under the Drugs Poisons and Controlled Substances Act 1981 or the Regulations under that Act or under a provision of a law in force in a place outside Victoria and which corresponds to a provision of Part V of that Act.
These are therefore in *Her Majesty's/*His Majesty's name—
*(1) to authorize you or any other police officer to enter and search the said *land or *premises or *specified vehicle located in a public place for the *things or *documents specified in this warrant and, if any of those *things or *documents be found, to seize and carry them before the Magistrates' Court so that the matter may be dealt with according to law or to destroy or dispose of them in accordance with section 81 of the Drugs, Poisons and Controlled Substances Act 1981 .
*(2) in relation to a specified thing or a specified document to
which this warrant relates which is also tainted property within the meaning
of the Confiscation Act 1997 , to direct you or any other police officer to
hold or retain that thing or document as if it were tainted property seized
under a warrant under section 79 of that Act as and from the date when that
thing or document is no longer required for evidentiary purposes under the
Drugs,
Poisons and Controlled Substances Act 1981.
Signed this day
of
*Magistrate
*Strike out whichever is not applicable.
Note: Under section 81(3) of the Drugs, Poisons and Controlled Substances Act 1981 , a police officer to whom a warrant under section 81(1) of that Act is addressed or any other police officer may, at any time or times by day or night but within one month from the date of the warrant and with such assistance as may be necessary—
(a) enter, if need be by force, the land or premises or specified vehicle located in a public place named in the warrant; and
(b) arrest all persons on or in that land or those premises or on or in that vehicle who are found offending against a provision of that Act or the regulations made under that Act; and
(c) search—
(i) the land or premises or any vehicle or any person found on or in that land or those premises or any person found on or in any vehicle on or in that land or those premises;
(ii) the specified vehicle located in a public place or any person found on or in that vehicle; and
(d) seize and carry away or, unless a direction under section 81(1A) of that Act applies, deal with as mentioned in paragraph (e)—
(i) any thing in respect of which an offence under that Act or the regulations made under that Act has been or is reasonably suspected to have been committed; and
(ii) any thing which there is reasonable ground to believe will afford evidence of the commission of an offence under that Act or the regulations made under that Act; and
(iii) any document directly or indirectly relating to or concerning a transaction or dealing which is or would be, if carried out, an offence against that Act or the regulations made under that Act or under a provision of a law in force in a place outside Victoria corresponding to a provision of Part V of that Act; and
(e) if—
(i) the thing is—
(A) a drug of dependence or a substance that contains a drug of dependence; or
(B) a poison or controlled substance; or
(C) an instrument, device or substance that is or has been used or is capable of being used for or in the cultivation, manufacture, sale or use or in the preparation for cultivation, manufacture, sale or use of a drug of dependence; and
(ii) an analyst or botanist within the meaning of section 120 of that Act certifies in writing to the police officer executing the warrant that destruction or disposal of the thing is required in the interests of health or safety—
destroy or dispose of the thing after taking, where practicable, any samples
of it as are required for the purposes of that Act.
Sch. 11 substituted by No. 10002 s. 8(1), amended by S.R. No. 1/1985
(paras (1)–(9)), substituted by S.R. No. 268/1985, amended by No.
101/1986 s. 58(1)(h)(i)–(iii), S.R. Nos 138/1989 (para. (3)(a)
(b)), 314/1990 (para. (3)(a)–(g)), 69/1993 para. (3)(a)(b), No. 48/1997
ss 45(1)
(a)–(h)(2), 46, S.R. Nos 107/1999 regs 3(1)
(a)–(e)(2), 4, 85/2000 reg. 3, Nos 61/2001 s. 8, 63/2003
s. 49, 74/2004 s. 19(a)(b), 52/2006 ss 18– 20 (as amended
by No. 79/2006 s. 87), 57/2012 ss 5– 7, 9/2014 ss 13–
17, 40/2017 ss 20– 23, 3/2019
ss 14 – 17, 44/2022
s. 90.
Schedule Eleven
Part 1
Column 1 |
Column 2 |
Column 3 |
|
Quantity |
Quantity |
|
Kilograms |
Grams |
ACETORPHINE | |
2·0 |
N -ACETYLAMPHETAMINE |
2·0 |
2·0 |
ACETYLDIHYDROCODEINE |
10·0 |
100·0 |
ACETYLMETHADOL | |
2·0 |
N -ACETYLMETHYLAMPHETAMINE |
2·0 |
2·0 |
ALPRAZOLAM | |
0·5 |
ANILERIDINE | |
25·0 |
BARBITURATES |
2·0 |
50·0 |
1, 4-BENZODIAZEPINES not included elsewhere in this Part | |
|
BENZOXAZOCINES |
2·0 |
50·0 |
BENZETHIDINE | |
10·0 |
BENZYLMORPHINE | |
5·0 |
BEZITRAMIDE | |
5·0 |
BROMAZEPAM | |
3·0 |
4-BROMO-2,5-DIMETHOXYAMPHETAMINE |
|
|
4-BROMO-2,5-DIMETHOXYMETHYLAMPHETAMINE |
|
|
* * * * * | | |
BUFOTENINE | |
2·0 |
BUTORPHANOL |
1·5 |
2·0 |
CHLORAL HYDRATE |
2·0 |
50·0 |
CHLORDIAZEPOXIDE | |
5·0 |
1-CHLORO-1-PHENYL-2-AMINOPROPANE |
|
|
Column 1 |
Column 2 |
Column 3 |
---|---|---|
|
Quantity |
Quantity |
|
Kilograms |
Grams |
1-CHLORO-1-PHENYL-2-METHYLAMINO–PROPANE |
|
|
CLOBAZAM | |
5·0 |
CLONAZEPAM | |
2·5 |
CLONITAZENE | |
5·0 |
CODEINE (when in excess of 10·0 grams) |
2·0 |
100·0 |
CODEINE N -OXIDE | |
10·0 |
CODOXIME | |
10·0 |
DESOMORPHINE | |
2·0 |
DIAMPROMIDE | |
5·0 |
DIAZEPAM | |
2·0 |
DIETHYLPROPION |
2·0 |
50·0 |
N , N -DIETHYLTRYPTAMINE |
2·0 |
2·0 |
DIFENOXIN | |
5·0 |
DIHYDROCODEINE (when in excess of 5·0 grams) |
|
|
DIHYDROHYDROXYMORPHINE | |
2·0 |
DIHYDROMORPHINE | |
10·0 |
DIMENOXADOL | |
10·0 |
DIMEPHEPTANOL | |
10·0 |
2,5-DIMETHOXY-4-METHYLAMPHETAMINE |
|
|
N , N -DIMETHYLTRYPTAMINE |
0·5 |
0·5 |
DIOXAPHETYL BUTYRATE | |
2·0 |
DIPHENOXYLATE |
2·0 |
3·0 |
DIPIPANONE | |
10·0 |
ECGONINE | |
10·0 |
ETHYLMORPHINE |
2·0 |
2·0 |
N -ETHYL-1-PHENYLCYCLOHEXYLAMINE |
|
|
ETONITAZENE | |
5·0 |
Column 1 |
Column 2 |
Column 3 |
|
Quantity |
Quantity |
|
Kilograms |
Grams |
ETORPHINE |
2·0 |
2·0 |
ETOXERIDINE | |
5·0 |
FENTANYL |
0·05 |
0·005 |
FLUNITRAZEPAM | |
0·5 |
FLURAZEPAM | |
3·0 |
N -FORMYLAMPHETAMINE |
2·0 |
2·0 |
N -FORMYLMETHYLAMPHETAMINE |
2·0 |
2·0 |
FURETHIDINE | |
1·0 |
GLUTETHIMIDE |
2·0 |
100·0 |
HYDROCODONE | |
2·0 |
HYDROMORPHONE | |
2·0 |
HYDROXYAMPHETAMINE |
2·0 |
2·0 |
N -HYDROXY-3, 4-METHYLENEDIOXYAMPHETAMINE |
|
|
KETOBEMIDONE | |
2·0 |
LORAZEPAM | |
0·5 |
LYSERGAMIDE |
0·01 |
0·1 |
LYSERGIC ACID |
0·002 |
0·002 |
MECLOQUALONE |
50·0 |
50·0 |
MESCALINE |
7·5 |
7·5 |
METAZOCINE | |
7·0 |
METHADONE |
2·0 |
2·0 |
METHAQUALONE |
2·0 |
50·0 |
METHORPHAN | |
2·0 |
4-METHOXYAMPHETAMINE |
0·5 |
0·5 |
4-METHOXYMETHYLAMPHETAMINE |
0·5 |
0·5 |
5-METHOXY- N , N -DIETHYLTRYPTAMINE |
|
|
5-METHOXY- N , N -DIMETHYLTRYPTAMINE |
|
|
METHOXYAMPHETAMINES |
0·5 |
0·5 |
Column 1 |
Column 2 |
Column 3 |
---|---|---|
|
Quantity |
Quantity |
|
Kilograms |
Grams |
2-METHYLAMINO-PROPIOPHENONE (METHCATHINONE) |
|
|
METHYLDESORPHINE | |
2·0 |
METHYLDIHYDROMORPHINE | |
2·0 |
3,4-METHYLENEDIOXY- N -ETHYLAMPHETAMINE |
|
|
(3,4-METHYLENEDIOXYPHENYL)-2-BROMOPROPANE |
|
|
N -METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE (MBDB) |
|
|
1-(3,4-METHYLENEDIOXYPHENYL)-3-BROMOPROPANE |
|
|
(3,4-METHYLENEDIOXYPHENYL)-2-PROPANONE |
|
|
METHYLPHENIDATE |
2·0 |
5·0 |
METOPON | |
2·0 |
MONOACETYLMORPHINE | |
2·0 |
MORAMIDE |
2·0 |
2·0 |
MORPHERIDINE | |
2·0 |
MORPHINAN | |
2·0 |
MORPHINE |
1·5 |
2·0 |
MORPHINE N -OXIDE | |
2·0 |
MORPHINONE | |
2·0 |
MYROPHINE | |
20·0 |
NALBUPHINE |
1·5 |
2·0 |
NICOCODINE (when in excess of 0·1 grams) |
2·0 |
2·0 |
NICODICODINE (when in excess of 0·1 grams) |
|
|
NICOMORPHINE | |
2·0 |
NITRAZEPAM | |
1·0 |
7-NITRO-1,4-BENZODIAZEPINES not included elsewhere in this Part | |
|
Column 1 |
Column 2 |
Column 3 |
|
Quantity |
Quantity |
|
Kilograms |
Grams |
NORACYMETHADOL | |
2·0 |
NORCODEINE (when in excess of 10·0 grams) |
|
|
NORMETHADONE | |
5·0 |
NORMORPHINE | |
20·0 |
NORPIPANONE | |
10·0 |
OXAZEPAM | |
10·0 |
OXYCODONE | |
5·0 |
OXYMORPHONE |
2·0 |
2·0 |
PENTAZOCINE |
5·0 |
5·0 |
PETHIDINE |
5·0 |
10·0 |
PHENYLACYLMORPHAN | |
2·0 |
PHENADOXONE | |
10·0 |
PHENAMPROMIDE | |
10·0 |
PHENAZOCINE | |
1·0 |
PHENCYCLIDINE |
0·1 |
0·001 |
PHENDIMETRAZINE | |
5·0 |
PHENMETRAZINE | |
5·0 |
PHENOMORPHAN | |
5·0 |
PHENOPERIDINE | |
1·0 |
PHENTERMINE |
2·0 |
50·0 |
1-PHENYL-2-CHLOROPROPANE |
2·0 |
2·0 |
1-(1-PHENYLCYCLOHEXYL) PYRROLIDINE |
|
|
1-PHENYL-2-NITROPROPENE |
2·0 |
2·0 |
PHENYLPROPANOLAMINE (when in excess of 20·0 grams) |
|
|
PHENYL-2-PROPANONE OXIME |
2·0 |
2·0 |
PIMINODINE | |
10·0 |
| | |
| | |
Column 1 |
Column 2 |
Column 3 |
|
Quantity |
Quantity |
|
Kilograms |
Grams |
PIPERIDINE DERIVATIVES INCLUDING—ALLYLPRODINE, MEPRODINE, |
|
|
PIRITRAMIDE | |
1·0 |
PROHEPTAZINE | |
1·0 |
PROPERIDINE | |
25·0 |
PROPIRAM | |
2·0 |
PROPOXYPHENE |
2·0 |
2·0 |
PSILOCIN |
0·1 |
0·1 |
PSILOCYBIN |
0·1 |
0·1 |
TEMAZEPAM | |
3·0 |
THEBACON |
2·0 |
2·0 |
THEBAINE |
2·0 |
2·0 |
THIAMBUTENE | |
5·0 |
1-[1-(2-THIENYL) CYCLOHEXYL] PIPERIDINE |
|
|
TRIMEPERIDINE | |
10·0 |
Part 2
Column 1 |
Column 1A (Large Commercial Quantity) |
Column 2 (Commercial Quantity) |
Column 3 (Traffickable Quantity) |
Column 4 (Small Quantity) |
Plant |
Quantity |
Quantity |
Quantity |
Quantity |
Cannabis L . |
250 kg or |
25·0 kg or |
250·0 g or 10 plants |
50·0 g |
Erythroxylum coca Lam | |
80·0 kg |
800·0 g | |
Erythroxylum | |
80·0 kg |
800·0 g | |
Papaver bracteatum Lindley |
1000 plants |
10·0 kg or 250 plants |
100·0 g or 50 plants |
5 plants |
Papaver somniferum L., other than its seed |
1000 plants |
10·0 kg or 250 plants |
100·0 g or 50 plants |
5 plants |
Part 3
Column 1 Drug |
Column 1A (Large Commercial Quantity) Quantity |
Column 1B (Large Commercial Quantity) Quantity of mixture of substance and drug of dependence |
Column 2 (Commercial Quantity) Quantity |
Column 2A (Commercial Quantity) Quantity of mixture of substance and drug of dependence |
Column 2B (Automatic Forfeiture Quantity) Quantity |
Column 3 (Traffickable Quantity) Quantity of mixture of substance and drug of dependence |
Column 3A (Traffickable Quantity) Quantity |
Column 4 (Small Quantity) Quantity |
---|---|---|---|---|---|---|---|---|
AMPHETAMINE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g | |
0·75 g |
1-BENZYLPIPERAZINE (also known as BZP) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
BUPRENORPHINE | | | | | |
2·0g | | |
1,4-BUTANEDIOL (also known as 1,4-BD) (except for a lawful industrial purpose) |
- |
20 · 0 kg |
- |
2·0 kg |
600·0 g |
- |
10·0 g | |
COCAINE |
750·0 g |
1·0 kg |
250·0 g |
500·0 g |
30·0 g |
3·0 g | |
1·0 g |
DIACETYLMORPHINE (Heroin) |
500·0 g |
750·0 g |
50·0 g |
250·0 g |
30·0 g |
3·0 g |
- |
1·0 g |
EPHEDRINE (when in excess of 10·0 g) |
750·0 g | |
100·0 g | | | |
20·0 g | |
GAMMA BUTYROLACTONE (also known as GBL) (except for a lawful industrial purpose) |
- |
20·0 kg |
- |
2·0 kg |
- |
50·0 g |
- |
10·0 g |
HARMALINE | | | |
1·25 kg | |
20·0 g | | |
HARMINE | | | |
1·25 kg | |
20·0 g | | |
HARMINES (not included elsewhere in this Part) | | | |
1·25 kg | |
20·0 g | | |
4-HYDROXYBUTANOIC ACID (also known as GHB) |
- |
20·0 kg |
- |
2·0 kg |
- |
50·0 g |
- |
10·0 g |
KETAMINE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
LYSERGIC ACID DIETHYLAMIDE |
150·0 mg | |
50·0 mg | |
1·5 g |
150 mg | |
20 mg |
METHYLAMPHETAMINE |
500·0 g |
750·0 g |
50·0 g |
250·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
METHYLENEDIOXY-AMPHETAMINES |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g | |
0·75 g |
3,4-METHYLENEDIOXY-AMPHETAMINE (MDA) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g | |
0·75 g |
3,4-METHYLENEDIOXY- N -METHYLAMPHETAMINE (MDMA) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g | |
0·75 g |
3,4-METHYLENEDIOXYPYROVALERONE (also known as MDPV) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
4-METHYLMETHCATHINONE (also known as 4-MMC) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
PHENYL-2-PROPANONE | |
1·0 kg | |
500·0 g | |
3·0 g | | |
PSEUDOEPHEDRINE (when in excess of 10·0g) |
750·0 g | |
100·0 g | | | |
20·0 g | |
TETRAH TETRAHYDROCANNABINOL |
3·0 kg |
25·0 kg |
1·0 kg |
10·0 kg |
600·0 g |
25·0 g | |
1·0 g |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
ANABOLIC AND ANDROGENIC STEROIDAL AGENTS, other than in implant preparations for use in animals | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
ATAMESTANE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
BOLANDIOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
BOLASTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
BOLAZINE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
BOLDENONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
BOLENOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
CALUSTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
CHLORANDROSTENOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
CLOSTEBOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
DANAZOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
DIHYDROLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
DIMETHANDROSTANOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
DROSTANOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
ENESTEBOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
EPITIOSTANOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
ETHYLDIENOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
ETHYLOESTRENOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
FLUOXYMESTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
FORMEBOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
FURAZABOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
HYDROXYSTENOZOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MEBOLAZINE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MEPITIOSTANE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MESABOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MESTANOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MESTEROLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHANDIENONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHANDRIOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHENOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHYLCLOSTEBOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHYLTESTOSTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METHYLTRIENOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
METRIBOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
MIBOLERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NANDROLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NORANDROSTENOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NORBOLETHONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NORCLOSTEBOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NORETHANDROLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
NORMETHANDRONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
OVANDROTONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
OXABOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
OXANDROLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
OXYMESTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
OXYMETHOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
PRASTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
PROPETANDROL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
QUINBOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
ROXIBOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
SILANDRONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
STANOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
STANOZOLOL | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
STENBOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
TESTOLACTONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
TESTOSTERONE, other than in implant preparations for use in animals | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
THIOMESTERONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
TRENBOLONE, other than in implant preparations for use in animals | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
TRESTOLONE | | |
5·0 kg |
5·0 kg |
300·0 g |
500·0 g | |
50·0 g |
The following SYNTHETIC CANNABINOIDS |
- |
- |
- |
- |
- |
- |
- |
- |
(1-(5-FLUOROPENTYL)-3-(2‑IODOBENZOYL)INDOLE) (common name AM-694) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL (common names cannibicyclohexanol and CP 47,497 C8 homologue) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL (common name CP 47,497) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
2-(2-METHOXYPHENYL)-1-(1‑PENTYLINDOL-3-YL)ETHANONE (common name JWH-250) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
| | | | | | | | |
(1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPHTHALEN-1-YLMETHANONE (common name JWH-200) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
NAPHTHALEN-1-YL-(1‑BUTYLINDOL-3-YL)METHANONE (common name JWH-073) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
1-PENTYL-3-(4-METHYL-1‑NAPHTHOYL)INDOLE (common name JWH-122) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
1-PENTYL-3-(1‑NAPHTHOYL)INDOLE (common name JWH-018) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
(1-PENTYLINDOL-3-YL)-(2,2,3,3-TETRAMETHYLCYCLOPROPYL) METHANONE (UR-144) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
(1-(5-FLUOROPENTYL)INDOL-3-YL)-(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE (XLR-11) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -(1-ADAMANTYL)-1-PENTYLINDAZOLE-3-CARBOXAMIDE (AKB48 OR APINACA) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -(1-FENCHYL)-1-(2-MORPHOLINOETHYL)-7-METHOXYINDOLE-3-CARBOXAMIDE (UR-12) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
1-(5-FLUOROPENTYL)-INDOLE-3-CARBOXYLIC ACID 8-QUINOLINYL ESTER (5F-PB-22) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -[1-(AMINOCARBONYL)-2-METHYLPROPYL]-1-PENTYLINDAZOLE-3-CARBOXAMIDE (common name AB-PINACA) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -[1-(AMINOCARBONYL)-2-METHYLPROPYL]-1-(CYCLOHEXYLMETHYL)
|
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -[1-(METHOXYCARBONYL)-2,2-DIMETHYLPROPYL]-1-(CYCLOHEXYLMETHYL)
|
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
N -[1-(AMINOCARBONYL)-2-METHYLPROPYL]-1-[(4-FLUOROPHENYL)
|
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
The following classes of SYNTHETIC CANNABINOIDS |
- |
- |
- |
- |
- |
- |
- |
- | ||||
3-BENZOYLINDOLES with any modification on the indole nitrogen, whether or not further modified on the indole or phenyl rings (other than a substance included elsewhere in this Part) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
3-PHENYLACETYLINDOLES with any modification on the indole nitrogen, whether or not further modified on the indole or phenyl rings (other than a substance included elsewhere in this Part) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
6,6-DIMETHYL-6 H -DIBENZO[b,d]-PYRANS with any modification at the 3‑position by alkyl or alkenyl, whether or not further modified on the cyclic rings, and whether or not the cyclic rings are partially or fully hydrogenated |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
2-(3‑HYDROXYCYCLOHEXYL)-PHENOLS with any modification at the 5-position of the phenolic ring, whether or not further modified on the cyclohexyl ring (other than a substance included elsewhere in this Part) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
3-(1-NAPHTHOYL)INDOLES with any modification on the indole nitrogen, whether or not further modified on the indole, naphthoyl or naphthyl rings (other than a substance included elsewhere in this Part) |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
3-(1‑NAPHTHYLMETHANE)INDOLES with any modification on the indole nitrogen, whether or not further modified on the indole, naphthoyl or naphthyl rings |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
| | | | | | | | | ||||
| | | | | | | | | ||||
3-(1-NAPHTHOYL)PYRROLES with any modification on the pyrrole nitrogen, whether or not further modified on the pyrrole or naphthoyl rings |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g | ||||
1-(1‑NAPHTHYLMETHYLENE)INDENES with any modification at the 3-position of the indene ring, whether or not further modified on the indene or naphthyl rings |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
(INDOL-3-YL)-(2,2,3,3-TETRA-ALKYLCYCLOPROPYL) METHANONES with any modification on the indole nitrogen, whether or not further modified on the indole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
3-(1-ADAMANTOYL)-INDOLES with any modification on the indole nitrogen, whether or not further modified on the indole or adamantane ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
N -(1-ADAMANTYL)-INDAZOLE-3-CARBOXAMIDES with any modification on the indazole nitrogen, whether or not further modified on the indazole or adamantane ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1.0 g |
N -(1-FENCHYL)-INDOLE-3-CARBOXAMIDES with any modification on the indole nitrogen, whether or not further modified on the indole or fenchane ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
INDOLE-3-CARBOXYLIC ACID, QUINOLINYL ESTERS with any modification on the indole nitrogen, whether or not further modified on the indole or quinolinyl ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
AZAINDOLE-3-CARBOXAMIDES with any modification on the azaindole or amide nitrogens, whether or not further modified on the azaindole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
| ||||||||
INDAZOLE-3-CARBOXAMIDES whether or not with any modification on the indazole or amide nitrogens, whether or not further modified on the indazole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
INDAZOLE-3-CARBOXYLATES with any modification on the indazole nitrogens or the carboxylate oxygen, whether or not further modified on the indazole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
INDOLE-3-CARBOXAMIDES with any modification on the indole or amide nitrogens, whether or not further modified on the indole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
INDOLE-3-CARBOXYLATES with any modification on the indole nitrogen or the carboxylate oxygen, whether or not further modified on the indole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
PYRAZOLE-3-CARBOXAMIDES with any modification on the pyrazole or amide nitrogens, whether or not further modified on the pyrazole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
PYRAZOLE-5-CARBOXAMIDES with any modification on the pyrazole or amide nitrogens, whether or not further modified on the pyrazole ring |
- |
10·0 kg |
- |
1·0 kg |
- |
3·0 g |
- |
1·0 g |
The following SYNTHETIC SUBSTANCES | | | | | | | | |
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE (2C-B / NEXUS) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
4-CHLORO-2,5-DIMETHOXYPHENETHYLAMINE (2C-C) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
2,5-DIMETHOXY-4-IODOPHENETHYLAMINE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
2,5-DIMETHOXY-4-FLUOROPHENETHYLAMINE (2C-F) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
2,5-DIMETHOXYPHENETHYLAMINE (2C-H) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
METHOXETAMINE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
alpha-PYRROLIDINOVALEROPHENONE (ALPHA-PVP) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
5-AMINOPROPYLBENZOFURAN (5-APB) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
6-AMINOPROPYLBENZOFURAN (6-APB) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
METHYLHEXANAMINE (DMAA) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
METHYLONE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
PENTYLONE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
ETHYLONE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
BUTYLONE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
PENTADRONE |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
DIMETHOCAINE |
750·0 g |
1·0 kg |
250.0 g |
500·0 g |
30·0 g |
3·0 g |
- |
1·0 g |
N -(2-METHOXYBENZYL)-2,5-DIMETHOXY-4-IODOPHENETHYLAMINE (25I-NBOMe) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
N -(2-METHOXYBENZYL)-4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE (25B-NBOMe) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
N -(2-METHOXYBENZYL)-4-CHLORO-2,5-DIMETHOXYPHENETHYLAMINE (25C-NBOMe) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
N -(2-METHOXYBENZYL)-2,5-DIMETHOXY-4-FLUOROPHENETHYLAMINE (25F-NBOMe) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
N -(2-METHOXYBENZYL)-2,5-DIMETHOXYPHENETHYLAMINE (25H-NBOMe) |
750·0 g |
1·0 kg |
100·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
0·75 g |
3,4-DICHLORO- N -([1-(DIMETHYLAMINO) |
750·0 g |
1·0 kg |
250·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
1·0 g |
N -[(1-AMINOCYCLOHEXYL) |
750·0 g |
1·0 kg |
250·0 g |
500·0 g |
30·0 g |
3·0 g |
- |
1·0 g |
Note: kg = kilogram
g = gram
mg = milligram
Schedule Twelve—Statements of strength of preparations
(a) In respect of a tablet, capsule, pastille, packaged single dose of powder, or similar discreet product unit, the quantity of each poison or controlled substance in the product unit.
(b) In respect of a solid preparation intended for extemporaneous preparation of either a single dose or a single stated amount of a liquid for therapeutic use, the quantity of each poison or controlled substance in the immediate container.
(c) In respect of a liquid for internal therapeutic use, the volume of the normal dose and the quantity of each poison or controlled substance in that volume.
(d) In respect of any other preparation, the portion of each poison or controlled substance shall be expressed as follows:
(i) In respect of a liquid poison or controlled substance in a liquid preparation, the weight or volume of the poison or controlled substance per stated volume of the preparation;
(ii) In respect of a liquid poison or controlled substance in a solid or semi-solid preparation, the weight or volume of the poison or controlled substance per stated weight of the preparation;
(iii) In respect of a solid or semi-solid poison or controlled substance in a liquid preparation, the weight of the poison or controlled substance per stated volume of the preparation;
(iv) In respect of a solid or semi-solid poison or controlled substance in a solid or semi-solid preparation, the weight of the poison or controlled substance per stated weight of the preparation;
(v) In respect of a gaseous poison or controlled substance in a liquid preparation, the weight of the poison or controlled substance per stated volume of the preparation;
(vi) In respect of a gaseous poison or controlled substance in a solid or semi-solid preparation, the weight of the poison or controlled substance per stated weight of the preparation;
(vii) In respect of a gaseous poison or controlled substance in a gaseous preparation, the weight of the poison or controlled substance per stated weight of the preparation.
Í Í Í Í Í Í Í Í Í Í Í Í Í Í Í